13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q3 2018. See the latest, Q2 2026 →
Reported value
$3.31B
+21% on the quarter before
Positions
202
19 new · 17 sold out
Top 10
40.3%
of the value
Est. gain
+$166.9M
on stocks held all quarter
Est. return
+6.9%
on those stocks since Q2 2018
Positions as of Sep 30, 2018, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2018. Striped tiles are options.
Largest buys
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$80.2MAdded · 5.6% → 6.0%+302,851 shares
- Tencent Holdings Ltd~$65.4MAdded · 2.1% → 3.4%+1,601,916 shares
- Baidu~$44.4MAdded · 3.7% → 4.2%+194,030 shares
- Crispr Therapeutics Ag~$43.7MAdded · 1.0% → 1.9%+986,450 shares
- Jd.Com Inc~$41.7MAdded · 2.5% → 2.7%+1,596,528 shares
- Twitter Inc~$38.9MAdded · 4.4% → 3.5%+1,365,200 shares
- Zillow Group Inc~$37.8MAdded · 0.3% → 1.3%+853,288 shares
- Intellia Therapeutics Inc~$35.5MAdded · 4.5% → 5.0%+1,240,206 shares
- Lendingtree Inc~$23.8MAdded · 0.3% → 1.0%+103,300 shares
- Bluebird Bio Inc~$20.0MAdded · 1.5% → 1.8%+137,323 shares
Largest sells
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Athenahealth Inc~$73.7MCut · 3.2% → 0.0%−548,715 shares
- Apple~$35.1MCut · 2.9% → 1.8%−155,446 shares
- Block~$33.1MCut · 3.1% → 3.1%−334,411 shares
- Amazon~$26.7MCut · 3.2% → 2.3%−13,332 shares
- Redfin Corp~$24.1MCut · 1.1% → 0.0%−1,290,913 shares
- Illumina Inc~$22.8MCut · 3.4% → 3.0%−62,044 shares
- Microsoft~$20.0MCut · 1.1% → 0.5%−174,920 shares
- Salesforce~$18.5MCut · 1.8% → 1.2%−116,375 shares
- Meta~$12.8MSold out · 0.5% → 0.0%−65,637 shares
- Softbank Group Corp~$7.1MCut · 0.4% → 0.2%−142,846 shares
Holdings
As of Sep 30, 2018. Changes are in shares against Jun 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares +68% · price −22.8% | 6.0% | $197.7M | −$34.7M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +27% · price +4.6% | 5.0% | $164.7M | +$5.7M | ||||||||
| Stratasys LtdCommon Stock · shares +1.5% · price +20.7% | 4.8% | $159.7M | +$27.0M | ||||||||
| Invitae CorpCommon Stock · shares +4.0% · price +127.6% | 4.6% | $153.4M | +$82.7M | ||||||||
| BaiduADR · shares +47% · price −5.9% | 4.2% | $139.4M | −$5.9M | ||||||||
| Twitter IncCommon Stock · shares +50% · price −34.8% | 3.5% | $117.3M | −$41.9M | ||||||||
| Tencent Holdings LtdADR · shares +143% · price −18.7% | 3.4% | $111.2M | −$10.5M | ||||||||
| BlockCommon Stock · shares −24% · price +60.6% | 3.1% | $102.2M | +$38.6M | ||||||||
| Illumina IncCommon Stock · shares −19% · price +31.4% | 3.0% | $99.4M | +$23.8M | ||||||||
| NvidiaCommon Stock · shares +2.3% · price +18.6% | 2.7% | $89.6M | +$13.7M | ||||||||
| Editas Medicine IncCommon Stock · shares +28% · price −11.2% | 2.7% | $88.9M | −$8.7M | ||||||||
| Jd.Com IncADR · shares +90% · price −33.0% | 2.7% | $87.8M | −$22.7M | ||||||||
| NetflixCommon Stock · shares +15% · price −4.4% | 2.3% | $77.0M | −$3.1M | ||||||||
| AmazonCommon Stock · shares −26% · price +17.8% | 2.3% | $76.2M | +$11.5M | ||||||||
| Lendingclub CorpCommon Stock · shares +16% · price +2.4% | 2.1% | $69.8M | +$1.4M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +211% · price −24.5% | 1.9% | $64.5M | −$6.7M | ||||||||
| TeradyneCommon Stock · shares +18% · price −2.9% | 1.9% | $64.0M | −$1.6M | ||||||||
| Nanostring Technologies IncCommon Stock · shares +31% · price +30.3% | 1.9% | $61.2M | +$10.9M | ||||||||
| AppleCommon Stock · shares −37% · price +21.9% | 1.8% | $60.4M | +$10.9M | ||||||||
| Red Hat IncCommon Stock · shares +27% · price +1.4% | 1.8% | $59.1M | +$653,038 | ||||||||
| Medidata Solutions IncCommon Stock · shares +28% · price −9.0% | 1.8% | $59.0M | −$4.6M | ||||||||
| Bluebird Bio IncCommon Stock · shares +52% · price −7.0% | 1.8% | $58.5M | −$2.9M | ||||||||
| Aptiv PlcCommon Stock · shares +41% · price −8.4% | 1.6% | $51.4M | −$3.4M | ||||||||
| Xilinx IncCommon Stock · shares −11% · price +22.8% | 1.5% | $50.9M | +$9.5M | ||||||||
| Spotify Technology SaCommon Stock · shares +37% · price +7.5% | 1.5% | $50.2M | +$2.5M | ||||||||
| Total · 202 positions | 100% | $3.31B | +$166.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2018 to Q3 2018: 183 stocks held throughout, up $166.9M (+6.9%).
- Invitae Corp+$82.7M+128%
- Block+$38.6M+61%
- Stratasys Ltd+$27.0M+21%
- Illumina Inc+$23.8M+31%
- Nvidia+$13.7M+19%
- Editas Medicine Inc−$8.7M−11%
- Tencent Holdings Ltd−$10.5M−19%
- Jd.Com Inc−$22.7M−33%
- Tesla−$34.7M−23%
- Twitter Inc−$41.9M−35%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |